JHP Pharmaceuticals has acquired King Pharmaceuticals's Rochester, Michigan sterile manufacturing facility, some of the legacy products, and the related contract manufacturing business, for approximately $93 million in cash.
Subscribe to our email newsletter
All current employees at the Rochester manufacturing facility have become JHP employees.
Peter Jenkins, CEO of JHP, said: “JHP is deeply appreciative of King’s support in the enormous amount of work that has been undertaken to ensure that the Rochester facility operates within the JHP corporate and technology platform from October 1.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.